Cargando…
Proceedings from the 2(nd) Next Gen Therapies for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome symposium held on October 3-4, 2019
For reasons poorly understood, and despite the availability of biological medications blocking IL-1 and IL-6 that have markedly improved overall disease control, children with Systemic Juvenile Idiopathic Arthritis (SJIA) are now increasingly diagnosed with life-threatening chronic complications, in...
Autores principales: | Canna, Scott W., Schulert, Grant S., de Jesus, Adriana, Pickering, Alex, Brunner, Hermine, Gadina, Massimo, Levine, Stewart, Goldbach-Mansky, Raphaela, Boutelle, Jonathan, Sinha, Rashmi, DeBenedetti, Fabrizio, Grom, Alexei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360380/ https://www.ncbi.nlm.nih.gov/pubmed/32664935 http://dx.doi.org/10.1186/s12969-020-00444-7 |
Ejemplares similares
-
Human Autoinflammatory Diseases Mediated by NLRP3-, Pyrin-, NLRP1-, and NLRC4-Inflammasome Dysregulation Updates on Diagnosis, Treatment, and the Respective Roles of IL-1 and IL-18
por: Alehashemi, Sara, et al.
Publicado: (2020) -
Editorial: Insights in autoimmune and autoinflammatory disorders: 2021
por: Goldbach-Mansky, Raphaela, et al.
Publicado: (2022) -
A novel STING1 variant causes a recessive form of STING-associated vasculopathy with onset in infancy (SAVI)
por: Lin, Bin, et al.
Publicado: (2020) -
Minutes of the meeting held on 2nd October 1978: CPS and SPS timing synchronisation
por: Riunaud, JP
Publicado: (1978) -
Serum IL-18 is a specific biomarker for Macrophage Activation Syndrome across several autoinflammatory diseases
por: Canna, SW, et al.
Publicado: (2015)